about
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsProcalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature.Prognostic value of procalcitonin in respiratory tract infections across clinical settings.Main characteristics observed in patients with hematologic diseases admitted to an intensive care unit of a Brazilian university hospital.Candida parapsilosis endocarditis: a comparative review of the literature.Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.Fatal Staphylococcal infection following classic Dengue fever.Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers.Streptococcus sinensis endocarditis outside Hong Kong.Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.Enterobacteriaceae resistant to third generation cephalosporins upon hospital admission: risk factors and clinical outcomes.Human toxocariasis and pyogenic liver abscess: a possible association.Tropical pyomyositis and human toxocariasis: a clinical and experimental study.Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria.[Dengue: a new approach]Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?Opportunistic infections in patients with AIDS admitted to an university hospital of the Southeast of Brazil.Procalcitonin levels in schizophrenic patients and patients with sepsis.Increased prevalence of human T cell lymphotropic virus type 1 in patients attending a Brazilian dermatology clinic.Respiratory failure due to opportunistic diseases in AIDS.Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.[Dermatologic lesions in patients infected with the human T-cell lymphotropic virus type 1 (HTLV-1)].Warfarin drug interactions: a comparative evaluation of the lists provided by five information sourcesSchistosomal myeloradiculopathy due to Schistosoma mansoni: report on 23 casesSchistosomiasis mansoni is associated with pyogenic liver abscesses in the state of Minas Gerais, BrazilHepatosplenic schistosomiasis in field-based studies: a combined clinical and sonographic definitionVisceral larva migrans syndrome complicated by liver abscessOutbreaks of pythiosis in two flocks of sheep in northeastern BrazilAlteration in the endogenous intestinal flora of Swiss Webster mice by experimental Angiostrongylus costaricensis infectionThe authors replyThe authors reply
P50
Q24200676-C681B508-3484-4B77-9992-A132D54A3DBAQ34264291-44C1C650-1C08-4F09-8CFA-BBB1AB43E7C2Q34704814-88AF436E-3F1B-4FE3-9511-B6CADCC416E2Q35247489-54EBEB3C-2E2C-4340-A743-512B509215E8Q36116786-6CC65FC7-A8B1-454E-BFE9-CC3FD41E2980Q36931732-62201CFB-A2BF-41B1-8DFF-66500406C220Q38123442-D7638C15-B34E-429A-B62D-02B7CEF5517FQ38878669-E08E2DFE-3F85-4860-8B42-6AABF0A4B053Q39158526-29C04B72-F6DF-4E1B-944C-180C57F1AE01Q39255384-F8C148A2-0D11-4C08-94F3-B5E1B7B00BBAQ39307447-6EC37E95-9D54-48B4-B9FD-6802496FF444Q39322190-AB3977CD-A253-4C58-B5C2-B21B395ECEFCQ39387393-71EA06AE-1D5B-4178-B175-FF1E4FF4A51FQ39387398-B3138B96-C7E6-4DFE-B37C-F8546BCF4043Q40040797-AF511565-4703-4A48-A97A-05EC5D6AEAA5Q40612596-1C7C34CC-4C0D-4104-B0DB-6321022C04E9Q41549121-86572ADC-1E79-4CFE-8626-A0C3B3B948D8Q43778459-FF0042B4-6FAC-429B-ADD8-3E2F68322053Q44200379-A7AFCB1F-9FDE-4AD3-ABCC-1CED49E86CAFQ44581552-80F7B6DF-8229-4334-BDDD-07EFCD8721A1Q45402068-875E7587-FF7E-4A1A-891A-E8E5FEA8C403Q51707518-1B3AD58F-0C1C-4C37-B710-88A81D6DADCDQ51898034-FC5E428A-618E-4C75-9B51-0C3E6597CA30Q55239509-097BB6E6-403A-465C-82FE-E51112136B36Q58847627-D81E1FEC-1C73-4397-8971-CED2013E58D8Q74592338-C941970A-5DAD-473E-AE17-827B24ABA6EDQ74592344-500C402C-2971-4714-AC32-2822C50B06E1Q74592349-058ABB89-8703-424D-BB58-AD7C783C2114Q78244982-FAF81E5D-D292-4C16-95D2-64B8CFF7A204Q80276870-47E669CE-443D-4EC2-BB25-BDDF97809516Q81282381-965D6534-C3A7-4C68-BEA6-B87778E8A8E9Q95516696-FB819669-65E8-4D56-86A5-F041622515EFQ95565821-95866F59-42EC-41E6-BA0F-C7DA2A627F53
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vandack Nobre
@ast
Vandack Nobre
@en
Vandack Nobre
@es
Vandack Nobre
@sl
type
label
Vandack Nobre
@ast
Vandack Nobre
@en
Vandack Nobre
@es
Vandack Nobre
@sl
prefLabel
Vandack Nobre
@ast
Vandack Nobre
@en
Vandack Nobre
@es
Vandack Nobre
@sl
P106
P31
P496
0000-0002-7922-0422